Additional file 1 of Pre-hospital glycemia as a biomarker for in-hospital all-cause mortality in diabetic patients - a pilot study

Supplementary Material 1: Table 1 HbA1c, glycosylated haemoglobin; CKD, chronic kidney disease; TIA, transient ischemic attack; PAD, peripheral arterial disease; COPD, chronic obstructive pulmonary disease; T2DM, type 2 diabetes mellitus; DPP-4is, dipeptidyl peptidase 4 inhibitors; GLP-1 RAs, glucagon-like peptide 1 receptor agonists; SGLT-2is, sodium-glucose co-transporter 2 inhibitors. Fig. 1 Design of the study. I/E = Inclusion/Exclusion; SD = standard deviation; CV = coefficient of variation.